ArticleArchives of Razi Institute2022
Epidemiological and Clinical Comparative Study for COVID-19 Patients in Babylon Province, Iraq.
Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular and Clinical Study of Bovine Coronavirus andVeterinary medicine international · 2026Article
- COVID-19 Vaccination Among Diverse Population Groups in the Northern Governorates of Iraq.International journal of public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A respiratory illness outbreak caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) began in China and spread to other nations. Typically, the real-time reverse transcriptase polymerase chain reaction of nasopharyngeal swabs has been utilized to confirm the clinical diagnosis. However, it is uncertain if the virus is found in specimens from other places, and therefore, possibly transmitted in methods other than respiratory droplets. Patients with coronavirus disease 2019 (COVID-19) were identified based on symptoms, and SARS-CoV-2 detection confirmed the diagnosis. Pharyngeal swabs were obtained from August to September 2020. Individuals with obtained samples based on clinical indications from hospitals in Marjan City and a public health laboratory in Babylon Province, Iraq, were included in this retrospective study. The findings of the clinical symptoms and their intensity were provided in the chart, which revealed that all indications were equal in both male and female patients, with no obvious differences, especially given that all patients' ages ranged from 30 to 70 years. High temperature, sore throat, and shortness of breath were shown to be the most common symptoms, in comparison to other symptoms in the chart.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.